* Aspen Aerogels Inc ASPN.N reported quarterly adjusted
earnings
of 14 cents per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of -1 cents. The mean expectation of
eleven analysts for the quarter was for earnings of 9 cents per
share. Wall Street expected results to range from 3 cents to 14
cents per share.
* Revenue rose 46.2% to $123.09 million from a year ago;
analysts
expected $120.80 million.
* Aspen Aerogels Inc's reported EPS for the quarter was 14
cents.
* The company reported quarterly net income of $11.36
million.
* Aspen Aerogels Inc shares had risen by 2.2% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the specialty
chemicals
peer group is also "buy"
Wall Street's median 12-month price target for Aspen Aerogels
Inc is $25.00
This summary was machine generated from LSEG data February 12 at
10:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 0.09 0.14 Beat
Sep. 30 2024 -0.08 0.19 Beat
Jun. 30 2024 0.05 0.21 Beat
Mar. 31 2024 -0.11 -0.02 Beat